欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2130/003
药品名称
Ramipril "Teva"
活性成分
ramipril 5.0 mg
剂型
Tablet
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands
参考成员国 - 产品名称
Denmark (DK)
Ramapril Teva
互认成员国 - 产品名称
Spain (ES)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Sweden (SE)
许可日期
2013/03/13
最近更新日期
2024/04/04
药物ATC编码
C09AA05 ramipril
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
Ramipril_DK_H_2130_001_004_PIL_07_03_22
Date of last change:2023/07/31
Final SPC
|
Ramipril_DK_H_2130_001_004_SmPC_07_03_22
Date of last change:2023/07/31
Final Labelling
|
Ramipril-DK_H_2130_001-004-OuP-15.03.19
Date of last change:2019/08/15
PAR
|
Final PAR Scientific discussion Ramipril Teva DKH2130_001-004_DC
Date of last change:2014/04/04
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase